- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage III Non-small-cell Lung Cancer in Korea, Democratic People's Republic of
Total 723 results
-
National Cancer Center, KoreaUnknownLung CancerKorea, Republic of
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
National Cancer Center, KoreaUnknownLung CancerKorea, Republic of
-
Samsung Medical CenterRecruitingNon Small Cell Lung Cancer | Brain MetastasesKorea, Republic of
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
Yonsei UniversityUnknownNon-DM Stage II High-risk Colorectal Cancer | Non-DM Stage III Colorectal CancerKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Korea University Guro HospitalChong Kun Dang Pharmaceutical Corp.Active, not recruitingEGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
Dong-A University HospitalCompletedColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
PfizerCompletedNon-small Cell Lung CancerKorea, Republic of, United States
-
Ono Pharmaceutical Co. LtdCompletedAdvanced Non-small Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
Dong-A University HospitalCompletedPancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
STCube, Inc.RecruitingExtensive Stage Small Cell Lung CancerUnited States, Korea, Republic of
-
Samsung Medical CenterNational Evidence-Based Healthcare Collaborating AgencyRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
PfizerCompletedCarcinoma, Non Small Cell LungKorea, Republic of
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
Genzyme, a Sanofi CompanyCompleted
-
Wellmarker BioMerck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingStage II Colon Cancer | Stage III Colon CancerKorea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
National Cancer Center, KoreaMerck Sharp & Dohme LLCUnknownNon-Small-Cell Lung CarcinomaKorea, Republic of
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Pusan National University HospitalYuhan CorporationNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
National Cancer Center, KoreaCompleted
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Eli Lilly and CompanyAstraZenecaCompletedNon-small Cell Lung CancerSpain, United States, Korea, Republic of, Taiwan, France
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterTerminated
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterUnknownNonsmall Cell Lung CancerKorea, Republic of
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Yonsei UniversityCompleted
-
Chonnam National University HospitalChong Kun Dang PharmaceuticalCompletedCarcinoma, Small CellKorea, Republic of
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Seoul National University HospitalCompletedSmall Cell Lung CancerKorea, Republic of
-
Seoul National University HospitalUnknownNon Small Cell Lung Cancer PatientsKorea, Republic of
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland